Popular Keywords

Acute Leukemia

CChemotherapy

Hematology

Hematopoiesis

Interferon therapy

Leukemia virus

SUBMIT MANUSCRIPT HERE

JOIN EDITORIAL-BOARD

PROPOSE SPECIAL ISSUE

Recent Articles

Are Closed Reduction and Percutaneous Pinning Enough in Oncology Patients with Non-Pathologic Fractures?

PDF FullText DOI: 10.52338/Jolr.2024.1005

Suspected Drug Eruption in a Patient with Chronic Lymphocytic Leukemia Caused by Eosinophilic Dermatosis of Hematologic Malignancy

PDF FullText DOI: 10.52338/Jolr.2024.1004

Associate in Nursing unnoticed Cause Throughout Coronary X-ray photography, vagal-induced cardiovascular disease

PDF FullText DOI: 10.52338/Jolr.2024.1003

Using Lean Six Sigma (LSS) and Total Quality Management (TQM), how to improve ineffective communication among care providers, which leads to medication errors in hospital settings – A Review

PDF FullText DOI: 10.52338/Jolr.2024.1002

A Case of Incidental Pelvic Schwannoma

PDF FullText DOI: 10.52338/Jolr.2024.1001

Journal Info

  • Journal Name: Journal of Leukemia Research
  • ISSN: 2831-3186
  • DOI: 10.52338/ Jolr
  • Short Name: JOLR
  • Acceptance rate: 55%
  • Volume: 6 (2024)
  • Submission to acceptance: 25 days
  • Acceptance to publication: 10 days
  • Crossref indexed journal
  • Publons indexed journal
  • Pubmed-indexed journal
  • International Scientific Indexing (ISI)-indexed journal
  • Eurasian Scientific Journal Index (ESJI) index journal
  • Semantic Scholar indexed journal
  • Cosmos indexed journal

OUR PUBLICATION BENEFITS

  • International Reach
  • Peer Review
  • Rapid Publication
  • Open Access
  • High Visibility